View of CLINICAL CHARACTERISTICS, ANXIETY LEVELS IN PATIENTS USING MEDLO (PHAs, Dipotassium glycyrrhizinate) FOR HERPES ZOSTER AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL AND FOB INTERNATIONAL COSMETIC DERMATOLOGY INSTITUTE FROM 2022 TO 2024

Return to Article Details CLINICAL CHARACTERISTICS, ANXIETY LEVELS IN PATIENTS USING MEDLO (PHAs, Dipotassium glycyrrhizinate) FOR HERPES ZOSTER AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL AND FOB INTERNATIONAL COSMETIC DERMATOLOGY INSTITUTE FROM 2022 TO 2024 Download Download PDF